CA2180762A1 - Administration d'un germicide pour eliminer helicobacter pylori - Google Patents

Administration d'un germicide pour eliminer helicobacter pylori

Info

Publication number: CA2180762A1
Authority: CA; Canada
Prior art keywords: stomach; infection; helicobacter pylori; bacteria; ulcers
Prior art date: 1996-07-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002180762A

Other languages

English (en)

Inventor

Peter Victor Nelson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-09

Filing date

1996-07-09

Publication date

1998-01-10

1996-07-09 Application filed by Individual filed Critical Individual

1996-07-09 Priority to CA002180762A priority Critical patent/CA2180762A1/fr

1998-01-10 Publication of CA2180762A1 publication Critical patent/CA2180762A1/fr

Status Abandoned legal-status Critical Current

Links

241000590002 Helicobacter pylori Species 0.000 title claims abstract description 10
230000002070 germicidal effect Effects 0.000 title claims description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 31
229940037467 helicobacter pylori Drugs 0.000 claims abstract description 9
239000003814 drug Substances 0.000 claims description 12
229940079593 drug Drugs 0.000 claims description 10
230000003115 biocidal effect Effects 0.000 claims description 6
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 3
229940069428 antacid Drugs 0.000 claims description 3
239000003159 antacid agent Substances 0.000 claims description 3
230000001458 anti-acid effect Effects 0.000 claims description 3
239000000463 material Substances 0.000 claims description 3
239000003795 chemical substances by application Substances 0.000 claims description 2
238000002483 medication Methods 0.000 claims description 2
239000000126 substance Substances 0.000 claims description 2
239000004150 EU approved colour Substances 0.000 claims 1
239000000427 antigen Substances 0.000 claims 1
102000036639 antigens Human genes 0.000 claims 1
108091007433 antigens Proteins 0.000 claims 1
235000015872 dietary supplement Nutrition 0.000 claims 1
239000003974 emollient agent Substances 0.000 claims 1
239000000284 extract Substances 0.000 claims 1
229910052500 inorganic mineral Inorganic materials 0.000 claims 1
239000011707 mineral Substances 0.000 claims 1
229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 claims 1
239000011782 vitamin Substances 0.000 claims 1
229940088594 vitamin Drugs 0.000 claims 1
229930003231 vitamin Natural products 0.000 claims 1
235000013343 vitamin Nutrition 0.000 claims 1
210000002784 stomach Anatomy 0.000 abstract description 26
208000025865 Ulcer Diseases 0.000 abstract description 18
231100000397 ulcer Toxicity 0.000 abstract description 18
239000003242 anti bacterial agent Substances 0.000 abstract description 14
208000007882 Gastritis Diseases 0.000 abstract description 13
229940088710 antibiotic agent Drugs 0.000 abstract description 13
208000015181 infectious disease Diseases 0.000 abstract description 9
206010028980 Neoplasm Diseases 0.000 abstract description 4
201000011510 cancer Diseases 0.000 abstract description 4
230000000694 effects Effects 0.000 abstract description 4
235000019441 ethanol Nutrition 0.000 description 21
241000894006 Bacteria Species 0.000 description 17
239000002253 acid Substances 0.000 description 14
238000011282 treatment Methods 0.000 description 9
229960004756 ethanol Drugs 0.000 description 6
201000006549 dyspepsia Diseases 0.000 description 5
208000024891 symptom Diseases 0.000 description 5
244000052616 bacterial pathogen Species 0.000 description 4
230000000740 bleeding effect Effects 0.000 description 4
239000008280 blood Substances 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
235000013305 food Nutrition 0.000 description 4
SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 3
206010020601 Hyperchlorhydria Diseases 0.000 description 3
206010061218 Inflammation Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
230000035876 healing Effects 0.000 description 3
208000024798 heartburn Diseases 0.000 description 3
230000004054 inflammatory process Effects 0.000 description 3
238000000034 method Methods 0.000 description 3
229960000282 metronidazole Drugs 0.000 description 3
VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 3
229960000381 omeprazole Drugs 0.000 description 3
239000000243 solution Substances 0.000 description 3
241000589989 Helicobacter Species 0.000 description 2
208000002193 Pain Diseases 0.000 description 2
208000008469 Peptic Ulcer Diseases 0.000 description 2
239000004098 Tetracycline Substances 0.000 description 2
229960003022 amoxicillin Drugs 0.000 description 2
LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 2
229960001380 cimetidine Drugs 0.000 description 2
CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000001066 destructive effect Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
230000035622 drinking Effects 0.000 description 2
210000003736 gastrointestinal content Anatomy 0.000 description 2
230000036541 health Effects 0.000 description 2
230000007794 irritation Effects 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 2
230000036407 pain Effects 0.000 description 2
229940101070 pepto-bismol Drugs 0.000 description 2
239000006187 pill Substances 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
238000011272 standard treatment Methods 0.000 description 2
230000035882 stress Effects 0.000 description 2
229960002180 tetracycline Drugs 0.000 description 2
229930101283 tetracycline Natural products 0.000 description 2
235000019364 tetracycline Nutrition 0.000 description 2
150000003522 tetracyclines Chemical class 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
206010002091 Anaesthesia Diseases 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
206010019375 Helicobacter infections Diseases 0.000 description 1
208000034991 Hiatal Hernia Diseases 0.000 description 1
206010020028 Hiatus hernia Diseases 0.000 description 1
229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 1
206010028813 Nausea Diseases 0.000 description 1
206010029216 Nervousness Diseases 0.000 description 1
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
208000005718 Stomach Neoplasms Diseases 0.000 description 1
235000013334 alcoholic beverage Nutrition 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
238000001949 anaesthesia Methods 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
235000013405 beer Nutrition 0.000 description 1
229960004645 bismuth subcitrate Drugs 0.000 description 1
ZQUAVILLCXTKTF-UHFFFAOYSA-H bismuth;tripotassium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].[K+].[K+].[Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ZQUAVILLCXTKTF-UHFFFAOYSA-H 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
208000037976 chronic inflammation Diseases 0.000 description 1
230000006020 chronic inflammation Effects 0.000 description 1
230000035602 clotting Effects 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
210000002249 digestive system Anatomy 0.000 description 1
239000012895 dilution Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
230000009429 distress Effects 0.000 description 1
239000000890 drug combination Substances 0.000 description 1
230000002183 duodenal effect Effects 0.000 description 1
208000000718 duodenal ulcer Diseases 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
230000003628 erosive effect Effects 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
210000004211 gastric acid Anatomy 0.000 description 1
206010017758 gastric cancer Diseases 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
230000036449 good health Effects 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
150000004679 hydroxides Chemical class 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
230000003902 lesion Effects 0.000 description 1
231100000636 lethal dose Toxicity 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000002075 main ingredient Substances 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
235000012054 meals Nutrition 0.000 description 1
230000008693 nausea Effects 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
229940018489 pronto Drugs 0.000 description 1
229940126409 proton pump inhibitor Drugs 0.000 description 1
239000000612 proton pump inhibitor Substances 0.000 description 1
VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
229960000620 ranitidine Drugs 0.000 description 1
238000011160 research Methods 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
235000021259 spicy food Nutrition 0.000 description 1
201000011549 stomach cancer Diseases 0.000 description 1
238000012360 testing method Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Emergency Medicine (AREA)
Plant Pathology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Birds (AREA)
Agronomy & Crop Science (AREA)
Pest Control & Pesticides (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Dentistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Environmental Sciences (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA002180762A 1996-07-09 1996-07-09 Administration d'un germicide pour eliminer helicobacter pylori Abandoned CA2180762A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA002180762A CA2180762A1 (fr)	1996-07-09	1996-07-09	Administration d'un germicide pour eliminer helicobacter pylori

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA002180762A CA2180762A1 (fr)	1996-07-09	1996-07-09	Administration d'un germicide pour eliminer helicobacter pylori

Publications (1)

Publication Number	Publication Date
CA2180762A1 true CA2180762A1 (fr)	1998-01-10

Family

ID=4158568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002180762A Abandoned CA2180762A1 (fr)	1996-07-09	1996-07-09	Administration d'un germicide pour eliminer helicobacter pylori

Country Status (1)

Country	Link
CA (1)	CA2180762A1 (fr)

1996
- 1996-07-09 CA CA002180762A patent/CA2180762A1/fr not_active Abandoned

Legal Events

Date	Code	Title	Description
1996-10-23	EEER	Examination request
2001-03-12	FZDE	Discontinued

Publication	Publication Date	Title
CA2029015C (fr)	1996-02-20	Compositions pharmaceutiques pour le traitement des douleurs gastro-intestinales
US4959384A (en)	1990-09-25	Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
CA2180762A1 (fr)	1998-01-10	Administration d'un germicide pour eliminer helicobacter pylori
CN1362259A (zh)	2002-08-07	印楝提取物在医药中的应用
CN105434459A (zh)	2016-03-30	一种治疗溃疡的西药配方及其制备工艺
Pratiwi et al.	2026	Guava leaf infusion for patients with acute diarrhoea
Boddu et al.	2015	Excipients and non-medicinal agents as active pharmaceutical ingredients
RU2039566C1 (ru)	1995-07-20	Способ лечения воспалительных и дистрофических заболеваний слизистых оболочек органов пищеварения
AU2008241370B2 (en)	2014-06-26	Essential oil of kunzea ambigua and methods of use
Goldfarb et al.	1985	A comparison of cimetidine and sucralfate in the treatment of bleeding peptic ulcers.
Kelly	1962	Preliminary observations on a new approach to treatment of peptic ulcer and digestive disorders
CN100469373C (zh)	2009-03-18	一种治疗褥疮的药物及其制备方法
CN102423319B (zh)	2014-06-11	治疗口腔溃疡的中药组合物
US9408883B2 (en)	2016-08-09	Essential oil of Kunzea ambigua and methods of use
Goode	1989	Insulinoma
Sutherland et al.	1988	ulcers
Savill	1896	ON THE PATHOLOGY OF ITCHING AND ITS TREATMENT BY LARGE DOSES OF CALCIUM CHLORIDE, WITH ILLUSTRATIVE CASES.
RU1790409C (ru)	1993-01-23	Способ лечени гнойно-воспалительного процесса
Crookston	1993	Communicating with our colleagues: Maintaining continuity in team care
Croftan	1912	New Clinical Therapeutics: A Handbook on the Special Treatment of Internal Disease
Taynor	1989	Sniper
PAMOATE	0	Communicating with our colleagues
Wythe	1868	The Physician's Dose and Symptom Book: Containing the Doses and Uses of All the Principal Articles of the Materia Medica and Officinal Preparations
LaMont et al.	1979	Peptic ulcer disease
Thomas	0	Medical Items and News